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Background: Continuous positive airway pressure (CPAP) is commonly used to relieve respiratory distress in infants
with bronchiolitis, but has mostly been studied in an intensive care setting. Our prime aim was to evaluate the
feasibility of CPAP for infants with bronchiolitis in a general paediatric ward, and secondary to assess capillary PCO2
(cPCO2) levels before and during treatment.
Methods: From May 1st 2008 to April 30th 2012, infants with bronchiolitis at Stavanger University Hospital were
treated with CPAP in a general paediatric ward, but could be referred to an intensive care unit (ICU) when needed,
according to in-house guidelines. Levels of cPCO2 were prospectively registered before the start of CPAP and at
approximately 4, 12, 24 and 48 hours of treatment as long as CPAP was given. We had a continuous updating
program for the nurses and physicians caring for the infants with CPAP. The study was population based.
Results: 672 infants (3.4%) were hospitalized with bronchiolitis. CPAP was initiated in 53 infants (0.3%; 7.9% of
infants with bronchiolitis), and was well tolerated in all but three infants. 46 infants were included in the study, the
majority of these (n = 33) were treated in the general ward only. These infants had lower cPCO2 before treatment
(8.0; 7.7, 8.6)(median; quartiles) than those treated at the ICU (n = 13) (9.3;8.5, 9.9) (p < 0.001). The level of cPCO2 was
significantly reduced after 4 h in both groups; 1.1 kPa (paediatric ward) (p < 0.001) and 1.3 kPa (ICU) (p = 0.002). Two
infants on the ICU did not respond to CPAP (increasing cPCO2 and severe apnoe) and were given mechanical
ventilation, otherwise no side effects were observed in either group treated with CPAP.
Conclusion: Treatment with CPAP for infants with bronchiolitis may be feasible in a general paediatric ward,
providing sufficient staffing and training, and the possibility of referral to an ICU when needed.
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Bronchiolitis is one of the most common reasons for
hospitalisation in infants [1-3]. Symptoms may include
coughing, wheezing, eating difficulties and apnoea. Bron-
chiolitis is commonly caused by respiratory syncytial virus
(RSV) occurring in epidemics during the winter season,
but other viruses may be involved [4]. Treatment is mainly
supportive, with oxygen, fluid therapy and respiratory sup-
port when needed [1-3]. Inhalations with (racemic) adren-
aline/epinephrine are commonly used in some countries,* Correspondence: knut.oymar@sus.no
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distribution, and reproduction in any mediumbut the evidence is sparse [5]. Recently, studies of inhala-
tions with hypertonic saline have been promising, but
more studies are awaited [6].
Patients at risk of severe bronchiolitis include infants
< 3 months of age, those with chronic lung disease after
prematurity, other chronic lung diseases, congenital
heart disease and neuromuscular impairment [1-3,7]. In
severe bronchiolitis, respiratory failure may develop in
spite of standard treatment; symptoms may then in-
clude apnoea, hypoxia and respiratory distress [7]. Low
oxygen saturation, high oxygen requirement and increas-
ing levels of CO2 (arterial or capillary) may indicate theCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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and mechanically ventilate an infant with bronchiolitis is
based on a combination of clinical signs and laboratory
results [8,9].
First described in 1981 [10], continuous positive air-
way pressure (CPAP) has been given to children with
severe bronchiolitis in order to support ventilation and
avoid the need for mechanical ventilation [8]. CPAP
works by keeping airways open, increasing clearance of
secretion, improving gas exchange and reducing the
work of breathing [11,12]. Two small randomised studies
have demonstrated the effect of CPAP on reducing ca-
pillary PCO2 and clinical scores [13,14]. Otherwise, only
observational studies has been published [10,11,15-19],
and no study has demonstrated that the use of CPAP
reduces the need for mechanical ventilation in children
with severe bronchiolitis [7,8].
In the published studies, the infants with bronchiolitis
were referred to an intensive care unit (ICU) [11,14-18]
or high dependency unit [19] when treated with CPAP.
Treatment in an ICU is resource demanding and may be
frightening for the parents. Treatment with CPAP in
general paediatric wards could possibly be easier and less
resource demanding; with a potentially lower threshold to
initiate treatment. At the paediatric department Stavanger
University Hospital we have during the four seasons
from May 1st 2008 to April 30th 2012 treated children
with bronchiolitis with a simple CPAP setup suitable for
general paediatric wards, with possible transfer to an
ICU when needed. In this article we present the results




Stavanger University Hospital is both a local and second-
ary referral hospital and the only hospital for children in
South Rogaland, Norway. The annual number of births
is approximately 5000 (2011). During the study period,
the paediatric ward for children with infectious diseases
had 11 beds in single-bed rooms. The ward was staffed
with eight nurses during daytime, six during weekends
and evenings and four during nights. Three physicians
attended the ward during daytime, and two were avail-
able during weekends, evenings and nights.
All nurses and physicians in the ward involved with
CPAP therapy were trained in practical and technical
details before being allowed to participate. An annual
training program before each bronchiolitis season was
established. Detailed written practical and technical pro-
cedures were available for both the physicians and
nurses.
The hospital further had a seven-bed ICU for patients
of all ages after the neonatal period, which alsoadmitted infants with bronchiolitis in need of intensive
care. Referral from the paediatric ward to the ICU
could be organised within a few minutes if necessary.
Bronchiolitis was defined as an acute respiratory in-
fection in a child < 12 months of age with typical symp-
toms of wheezing (prolonged expiration) [1-3]. Infants
with bronchiolitis needing hospitalisation were re-
ferred to the paediatric ward for infectious diseases.
Nasopharyngeal mucus was examined for RSV by dir-
ect immunofluorescence in all patients (bioMe’rieux,
Marcyl’E’toile, France).
The standard treatment for bronchiolitis in the de-
partment is oxygen when needed (to keep the oxygen
saturation ≥ 92-94%), fluid and nutritional support (by
nasogastric tube or intravenously). During the study
period, we regularly treated the infants with racemic
adrenaline if the child had bronchopulmonary obstruc-
tion or severe cough; 2–4 mg in 2 ml isotonic saline
every 2–4 hours as needed [5], or with only isotonic
saline when needed.
Traditionally, when an infant with bronchiolitis dem-
onstrate signs of respiratory failure we have referred the
infant to the ICU for treatment with CPAP or mechan-
ical ventilation. From 2008 we have aimed to initially
treat infants in need of CPAP in the general paediatric
ward without initial referral to the ICU. The study
period included four years from May 1st 2008 to April
30th 2012. Only children living in the area for Stavanger
University Hospital were included, making the study
population based.
CPAP – indications and setup
Children treated with CPAP were given oxygen, fluid
support and nebulised racemic adrenaline in advance.
The decision to start treatment with CPAP was taken by
the physician responsible, but according to in-house
guidelines (see list of criteria below).
List of criteria for starting treatment with continuous
positive airway pressure (CPAP) or referral to intensive
care unit (ICU) in infants with bronchiolitis at Stavanger
University Hospital
1. CPAP is considered for a child with bronchiolitis
with
a. Recurrent episodes of apnoea
b. Severe respiratory distress; retractions, severe
wheezing
c. Increasing oxygen supply in spite of other
treatment
d. Increasing capillary CO2 (> 6.5-7.0 kPa)
e. Young age (<2-3 months)
2. Referral to the ICU is considered when an infant
with bronchiolitis in spite of treatment with CPAP
at the paediatric ward have
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tachypnoe > 70/min)
b. High or increasing capillary CO2 (> 6.5-7.0 kPa)
c. Severe apnoea






























Figure 1 Overview of infants < 12 months of age hospitalized
for bronchiolitis during four years at Stavanger University
Hospital and the number of infants given continuous positive
airway pressure (CPAP) or mechanical ventilation. Infants were
either treated in a general paediatric ward or an intensive care unit
(ICU).* Four children excluded from the study due to chronic disease.In the paediatric ward we used the CPAP GoodKnight
420E® (Puritan Bennett, Coviden, Mansfield, MS, USA)
with two different nasal masks with leaks; ProfileLite
Small Child (Philips Respironics, Tangmere, UK) or In-
fant Bubble Mask (Sullivan Infant Bubble Mask, Resmed,
San Diego, CA, USA) which were individually adapted.
The CPAP pressure was set at 5 cm H2O in all cases.
Extra oxygen was given as 100% oxygen into the circuit
as needed to keep the SpO2 within excepted limits. The
nebuliser Aeroneb ProX (Aerogen, Galway, Ireland) was
connected to the circuit, allowing inhalations without
changing the gas flow to the patient, otherwise the gas
was not humidified. Careful nasal suctioning was per-
formed in infants with copious secretion.
For infants treated with CPAP in the ward, SpO2 was
continuously monitored by pulse oximetry. A nurse was
permanently in the room during the initial phase, during
weaning by frequent observations. One of the parents
was always with the child in the room. A physician could
attend immediately if necessary.
Referral to the ICU was considered if the child was
not successfully treated at the paediatric ward; according
to criteria given above. Infants referred to the ICU were
treated with nasal CPAP using the Dräger Evita XL ven-
tilator (Dräger Medical, Lübeck, Germany) with nasal
prongs (Fischer & Paykel Healthcare, Irvine, CA). Initial
CPAP pressure was set to 5 cm H2O.
We aimed at measuring a capillary PCO2 (cPCO2) be-
fore starting treatment with CPAP, 4–6 hours after
CPAP had been initiated, and approximately 12, 24 and
48 hours after the start of treatment if the infant was still
on CPAP. Samples for capillary PCO2 was taken and
analyzed by laboratorial staff. Data were prospectively
registered by nurses on a special record for the project,
missing data were retrospectively collected from hospital
records. Arterial blood gases were not measured and
respiratory distress not systematically registered.
We considered the procedure described as the best
treatment for bronchiolitis available based on the litera-
ture, and no control group was included [1-3,7]. The
procedure was therefore not considered as a research
protocol; the regional ethical committee was consulted
and waived the need for approval.
Statistics
Comparisons between groups were analysed by non-
parametric tests for variance; the Kruskal-Wallis test forindependent samples and Friedman test for related sam-
ples. A p-value < 0.05 was regarded as statistically sig-
nificant, and all analyses were two-tailed. Data were
analysed using the SPSS version 18.0 statistical package
(SPSS, Chicago, IL, USA).
Results
During the four winter seasons, a total number of 672
infants younger than 12 months of age were hospitalised
for bronchiolitis; 3.4% of all infants < one year of age in
the catchment area. Of these, 339 tested positive for
RSV (50%). In total, treatment with CPAP was initiated
in 53 infants with bronchiolitis during the four seasons;
0.3% of all infants < one year of age and 7.9% of all chil-
dren hospitalized for bronchiolitis. Three infants were
given mechanical ventilation for bronchiolitis during the
period (0.4%); one of these (age 10 months) was venti-
lated from admission without initial CPAP due to rapid
and severe clinical deterioration. Two infants failed on
CPAP and were given mechanical ventilation, one due to
high cPCO2 and respiratory distress and one infant due
to severe apnoea in spite of normal cPCO2 (Figure 1).
For three infants, treatment with CPAP were initiated,
but was unsuccessful due to non-cooperating child. Four
children were excluded from analyses due to other dis-
eases or treatment with CPAP < four hours (Figure 1).
Among the remaining 46 infants, 33 were treated with
CPAP only in the general paediatric ward. Thirteen were
referred to the ICU, for nine of those due to respiratory
distress in spite of CPAP given at the ward. Four
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vere respiratory distress at admission (Figure 1).
When analysing data, children treated only in the paedi-
atric ward and those treated in the ICU were compared.
Clinical characteristics and levels of cPCO2 before and
after four hours treatment with CPAP for both groups are
given in Table 1. Children treated in the ICU had a higher
cPCO2 before treatment and after 4 hours treatment with
CPAP compared to those only treated in the paediatric
ward, but no other significant differences were observed
between the groups.
The levels of cPCO2 before CPAP was given (n = 33/13)
and after 4 hours (n = 33/13), 12 hours (n = 21/10), and
24 hours (n = 14/7) for both groups are demonstrated in
Figure 2. For both groups there were a reduction in in
cPCO2 after four hours treatment, the reduction of the
median cPCO2 was 1.1 (paediatric ward only) and 1.3 kPa
(ICU) (p < 0.001 and p = 0.002) (Figure 2). In one child,
the cPCO2 increased from 8.4 kPa to 9.2 kPa 4 hours after
CPAP was initiated, but declined to 7.4 kPa the next
12 hours. Increasing cPCO2 was not observed in any other
infants after treatment with CPAP was initiated.
The CPAP was generally well tolerated. Except for the
three infants not cooperating, no significant side effects
were observed.
Discussion
The results of this study suggest that CPAP for infants
with bronchiolitis may be feasible in a general paedi-
atric ward for the majority of infants. We showed a
significant decline in median cPCO2 four hours after
the initiation of treatment also in this setting, the ma-
jority of infants tolerated CPAP well, and no signifi-
cant side effects were observed. However, sufficientTable 1 Clinical and laboratory characteristics in infants
with bronchiolitis treated with continuous positive
airway pressure (CPAP) at Stavanger University Hospital
during four years
Paediatric
ward N = 33
ICU n = 13 p-value
Gender (boys/girls) 17/16 10/3 0.184
Gestational age (weeks) 38 (34, 40) 37 (34, 38) 0.383
Age at admission (weeks) 34 (20, 61) 25 (18, 40) 0.157
RS-virus (yes/no) 26/7 11/2 0.712
cPCO2 before CPAP 8.0 (7.7, 8.6) 9.3 (8.5, 9.9) <0.001
cPCO2 4 hours 6.9 (6.6, 7.4) 8.0 (7.5, 8.5) <0.001
Duration of CPAP (hours) 24 (8, 44) 30 (19, 60) 0.195
Length of total hospital stay 7 (5, 8) 8 (6, 11) 0.085
Children in the first group were treated in the paediatric ward only, and
children in the second group in the intensive care unit (ICU) only (n = 4) or
referred to the ICU after treatment in the paediatric ward (n = 9). Results are
given as median (quartiles).and trained staffing and the possibility of referral to
an ICU should be a prerequisite for CPAP therapy in
general wards.
Our study may be the first to show the results of
treatment with CPAP in a general paediatric ward. In
the majority of children, referral to a higher level of
care was not necessary, and the effect of treatment
measured by cPCO2 was comparable to those treated
at the ICU and to the results in other studies. Treat-
ment in general wards may have economic benefits,
and be more convenient for the parents [20]. However, we
consider it mandatory that sufficient staffing (nurses
and physicians) are available, and that sufficient training
is provided. Moreover, as almost one third of the chil-
dren were in need of referral to an ICU, the possibility
for such referral must be easily available. Except for one
infant with severe apnoea in need of mechanical ventila-
tion, significant apnoea was not observed in any of the
infants treated with CPAP. This may however be more
common than observed by us, and may be a reason for
referral to and ICU.
The observed effect of CPAP on cPCO2 in our study is
in agreement with previous studies. The effect of CPAP
in bronchiolitis has so far been studied in only two small
randomized studies. In a blinded randomised cross-over
study by Thia et al., 31 children with bronchiolitis and a
capillary cPCO2 > 6 kPa were given either standard treat-
ment with or without CPAP for 12 hours. For those
given CPAP first, the mean reduction in cPCO2 was 1.35
kPa, which was more than for those given CPAP after
12 hours [13]. Recently, Milesi et al. demonstrated that
in 10 children with severe bronchiolitis, CPAP was ef-
fective in decreasing respiratory work compared to the 9
controls [14]. Both these studies emphasized the possible
importance of early introduction of CPAP in children
with severe bronchiolitis.
The other published studies have been observational
with a before-after design. Only one study has been per-
formed outside an ICU; Lazner et al. recently published
a retrospective study with from a high dependency unit
[19]. They found that different methods of non-invasive
ventilation, mainly CPAP with a preset-level, were effect-
ive in 80% of infants receiving this support. A beneficial
effect was seen both on the respiratory work, oxygen sat-
uration and cPCO2. The average levels of cPCO2 were
8.5 kPA before treatment and 7.3 kPa after 4 hours in
responders, in accordance with our results.
We did not aim to compare the efficacy of CPAP
between an ICU and general paediatric ward, as the in-
fants with more severe symptoms were referred to the
ICU. However, those referred to the ICU had higher
levels of cPCO2, suggesting that that this criterion may




Figure 2 Capillary PCO2 before the start of treatment with continuous positive airway pressure (CPAP) and 4, 12 and 24 hours after
the start of treatment in infants with bronchiolitis during four years at Stavanger University Hospital. Infants were either treated in a
ordinary paediatric ward only ward (lower line) or an intensive care unit (ICU) (upper line).
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scribed for infants treated with CPAP [11,14-16,19], and
the fear of side effects such as increasing cPCO2 or re-
spiratory distress when starting CPAP, does not seem to
be an argument against giving CPAP at a low level of
care. Giving CPAP in general wards may increase the
availability for this treatment, and open for the early
introduction of CPAP in infants with more moderate
symptoms. A recent study comparing to periods with
different strategies, suggests that a pre-emptive use of
CPAP in bronchiolitis may improve both clinical and
economic outcomes in infants with bronchiolitis [20].
The treatment with CPAP in our study included the
use of a nasal mask, and a continuous pressure of 5 cm
H2O. Nasal prongs have been used successfully in
other studies [21], and the choice of delivery system
may not be essential for the effect of the treatment. We
chose a CPAP apparatus produced for home ventila-
tion due to the simplicity of handling and because
compressed air was not needed. Recently, Essouri et al.
also suggested that a CPAP level of 7 cm H2O may
have the best effect on respiratory efforts in infants
with bronchiolitis [12].
As the present study was population based and con-
tinued for four whole years, it also adds epidemiological
based data regarding the number of children with bron-
chiolitis needing hospitalization, and how many will be
in need of ventilatory support. However, both these
variables may depend on local criteria for treatment.
The hospitalization rate observed by us may be slightly
higher than that observed in other studies both in
Norway [22] and other countries [2]. This may possibly
be explained by an increasing rate of hospitalization forbronchiolitis which has been observed [23]. We have
not identified other population based studies describing
the incidence of CPAP in children with bronchiolitis
below one year of age.
The population based design is a positive feature of
this study, as there was no selection of children on any
level. A weakness is that only cPCO2 was used as an
objective parameter of efficacy, and not respiratory work
or oxygen saturation. Relative few patients were included
in this single centre study, and larger studies including
more clinical parameters could be initiated to evaluate
the safety of giving CPAP in general wards.
In a recent review, Donlan et al. concluded that in
spite of the increasing use of CPAP in bronchiolitis, evi-
dence supporting the use of CPAP to reduce PCO2 and
respiratory distress in bronchiolitis is of low quality, and
that there is no evidence that CPAP reduces the need
for intubation [8]. Consequently, there is still need for
high quality randomized studies of the use of nasal
CPAP in children with bronchiolitis, not only to study
the effect of CPAP per se, but also to see if the early
introduction of CPAP in children with less severe symp-
toms may improve the outcome or the need for other
support such as mechanical ventilation.
Conclusion
Our results suggest that for infants with bronchiolitis in
need of treatment with CPAP, this therapy may be feas-
ible in a general paediatric ward for the majority of in-
fants, provided sufficient staff, training and monitoring.
This may have economic benefits, be preferable for par-
ents and permit for more infants to be treated with
CPAP for this common disease.
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